Why Biohaven Stock Zoomed More Than 6% Higher Today

It's always encouraging to get what appears to be good news from the FDA.On a very good Friday for the stock market, Biohaven's (BHVN 6.33%) performance was exceptional. The clinical-stage biotech's share price inflated by over 6% that trading session thanks to regulatory news it delivered in the morning. Even the surging S&P 500 index couldn't come close to that kind of increase, with its 1.5% gain on the day. Regulatory progressBiohaven revealed in a filing with the Securities and Exchange Commission (SEC ...